Into clinical practice:
Pneumonia
- HELD 6 APRIL 2022. REGISTER NOW TO ACCESS THE RECORDED CONTENT
THIS CONFERENCE IS CPD ACCREDITED AND WILL BE AVAILABLE UNTIL 6 OCTOBER 2022
Register below to view the recorded content from this online conference.
This conference is RCPath CPD accredited and will be available until 6 October 2022.
Programme
0945
Opening remarks
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
SESSION ONE: Epidemiology and Guidelines
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC
0950
INHALE update - incidence and prevalence
Professor David Livermore, Professor of Medical Microbiology, University of East Anglia - View Bio
1010
Impact of antimicrobial prescribing during the COVID-pandemic on MDRO colonisation and the gut microbiome
Dr Jane Freeman, Associate Professor / Clinical Scientist, University of Leeds / Leeds Teaching Hospitals - View Bio
1030
Q&A
1050
BREAK
SESSION TWO: The Patient and the pathway
Chair: Ms Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital
1100
Community-acquired pneumonia in 2022; an update on recent clinical research
Dr Stephen Aston, Senior Clinical Lecturer and Consultant in Infectious Diseases, University of Liverpool and Liverpool University Hospitals NHS Trust - View Bio
1120
Diagnostic and treatment challenges in HAP and VAP
Dr Tom Hellyer, Senior Clinical Fellow and Honorary Consultant Intensive Care Medicine, Newcastle University - View Bio
1140
Pneumonia- a broken diagnosis and the need for a different paradigm
Professor Matthew Inada-Kim, Consultant Acute Physician National Clinical Director – Infection management, AMR, Deterioration National Specialty advisor- Sepsis National Clinical Lead- COVID oximetry/virtual wards, Hampshire Hospitals NHS Foundation Trust NHS England and NHS Improvement - View Bio
1200
Q&A
1215
BREAK
SESSION THREE: Perspectives on the clinical use of antibiotics for difficult to treat pathogens in patients with cystic fibrosis (CF)
Supported by: Menarini
1225
Respiratory
Dr Jacqueline C. Rendall
1235
Microbiology
Professor John E. Moore
1245
Q&A
SESSION FOUR: Supported session
Supported by: Pfizer
1255
Severe Nosocomial Pneumonia, New Aspects after Guidelines
Professor Antoni Torres, Department of Pulmonology, Hospital Clinic, University of Barcelona, Spain - View Bio
1320
BREAK
SESSION FIVE: COVID-19
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC
1340
Antifungal stewardship and respiratory fungal disease
Dr Darius Armstrong-James, Reader in Infectious Diseases and Medical Mycology, Faculty of Medicine, Department of Infectious Disease - View Bio
1400
Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients
Professor Enitan Carrol, Professor of Paediatric Infection, University of Liverpool - View Bio
1420
Results of the CATALYST trial in hospitalised patients with COVID-19 pneumonia
Dr Benjamin Fisher, Senior Clinical Lecturer, University of Birmingham - View Bio
1440
Q&A
SESSION SIX: Supported session
Supported by: Shionogi
1500
Difficult to treat infections in critical care: a complex case study
Mr Stephen Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster Hospital NHS Foundation Trust - View Bio
1515
BREAK
SESSION SEVEN: Paediatrics
Chair: Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital
1525
Challenges of managing pneumonia in the paediatric patient - an area for antimicrobial stewardship
Dr Julia Bielicki Consultant in Paediatric Infectious Diseases, Lead Physician Infection Prevention and Control University of Basel Children’s Hospital - View Bio
1545
Paediatric Pneumonia - More research required
Dr Malcolm Brodlie, Clinical Senior Lecturer/Honorary Consultant in Paediatric Respiratory Medicine, Newcastle University/Great North Children’s Hospital - View Bio
1555
Q&A
SESSION EIGHT: A vision for the future
Chair: Professor Tony Whitehouse, Consultant Critical Care & Anaesthesia Honorary Professor, University of Birmingham
1615
What are the main drivers for change?
Professor Mervyn Singer, Professor of Intensive Care Medicine at University College London, past Chair of the International Sepsis Forum - View Bio
1630
What are the main drivers for change?
Dr Ron Daniels BEM, Executive Director, UK Sepsis Trust - View Bio
1645
Panel discussion
1715
Closing remarks
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
Registration
If you have any queries regarding registration, please contact Esme Carruthers
BSAC Members (NHS/not for profit) £40Register >
Non-members (NHS/not for profit) £65Register >
Commercial £200Register >
Student & LMIC concessions £25Register >
Abstract Submission
Abstract submission is now closed.
Having trouble finding what you're after?
© 2022, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
Registered Charity
